Reply to "Serum Neurofilaments as Candidate Biomarkers of Natalizumab Progressive Multifocal Leukoencephalopathy". Dalla Costa G, Martinelli V, Furlan R, Comi G, et al. Ann Neurol 2019;86:324.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dalla Costa G, Martinelli V, Furlan R, Comi G, et al. Reply to "Serum Neurofilaments as Candidate Biomarkers of Natalizumab Progressive Multifocal Leukoencephalopathy". Ann Neurol 2019;86:324.
PMID: 31187511